Diabetes, Obesity, COVID-19, Insulin, and Other Antidiabetes Drugs

Coronavirus disease 2019 (COVID-19) viral infection, like other infections, triggers an inflammatory response that is usually confined to the respiratory system. However, there evidence in a full-blown case, almost all systems of body may be involved. In addition, syndrome cytokine storm, characterized by severe systemic inflammation and massive release proinflammatory cytokines (1). It well established obesity diabetes are major risk factors for COVID-19 infections morbidity mortality association with these conditions markedly increased. Since both associated chronic inflammation, it likely to COVID-19 such patients affected background inflammation. This review aims elucidate some processes potential strategies combat them.